Evidence map›Paper›PMID 30579358›Full record

ArticleJournal of medical case reports2018

Episcleritis in a patient with mucosal melanoma treated with interferon alfa-2b and radiotherapy: a case report.

Li Yang, Shaofei Ji, Liping Wang, Yi Zhang

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Li YangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China.
Shaofei JiDepartment of Radiology, Orthopedics Hospital of Zhengzhou City, Zhengzhou, 450052, China.
Liping WangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Yi ZhangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China. yizhang@zzu.edu.cn.
First Affiliated Hospital of Zhengzhou University · CNZhengzhou City Hospital · CN

Funding

National Natural Science Foundation of China 81171986National Natural Science Foundation of China 81602024
6 · The paper itself

Abstract

backgroundMucosal melanoma of the head and neck is a rare malignant tumor associated with a poor prognosis. Surgery, chemotherapy, radiotherapy, and biotherapy are common strategies for treating mucosal melanoma of the head and neck. Episcleritis is an idiopathic, immune-mediated disease, and is classified into two types: simple episcleritis and nodular episcleritis. CASE PRESENTATION: In this case report we describe ocular changes involving simple episcleritis in a 65-year-old Chinese man with mucosal melanoma of the head and neck after treatment with interferon alfa-2b and radiotherapy. On the third day of interferon alfa-2b treatment, he began to develop simple episcleritis in his left eye. Moreover, the percentage of CD3

conclusionEpiscleritis in this patient might have been due to the treatment with interferon alfa-2b and radiotherapy, leading to an increase in the level of CD3

Indexed as

RadiotherapyAgedAnti-Bacterial AgentsAntineoplastic AgentsChemotherapy, AdjuvantCombined Modality TherapyHead and Neck NeoplasmsHumansInterferon alpha-2MaleMelanomaOfloxacinOphthalmic SolutionsPhenylephrineTreatment OutcomeAnti-Bacterial AgentsAntineoplastic AgentsInterferon alpha-2OfloxacinOphthalmic SolutionsPhenylephrineAnti-tumor immunityEpiscleritisImmune-mediatedInterferon alfa-2bMucosal melanoma of the head and neck (MMHN)RadiotherapyTumor immunology

Identifiers

PMID30579358
PMCPMC6304235
OpenAlexW2906394613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.